The global Biochemical Befense market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Biochemical Befense in various end use industries. The expanding demands from the National Defense, Military and Others,, are propelling Biochemical Befense market. Anthrax, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Smallpox segment is estimated at % CAGR for the next seven-year period.

Asia Pacific shows high growth potential for Biochemical Befense market, driven by demand from China, the second largest economy with some signs of stabilising, the Biochemical Befense market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biochemical Befense, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Biochemical Befense market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Biochemical Befense market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biochemical Befense sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Biochemical Befense covered in this report include Emergent Biosolutions, Hytest, GSK, Sanofi, PharmAthene, Bavarian Nordic, SIGA Technologies, Arbutus Biopharma and DynPort Vaccine, etc.

The global Biochemical Befense market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Emergent Biosolutions

Hytest

GSK

Sanofi

PharmAthene

Bavarian Nordic

SIGA Technologies

Arbutus Biopharma

DynPort Vaccine

Xoma Corporation

Ichor Medical Systems

Aeolus Pharmaceuticals

Achaogen

Elusys Therapeutics

Dynavax Technologies

Cleveland BioLabs

Soligenix

Alnylam Pharmaceuticals

Scope of Biochemical Befense - Market Report

Report Metric	Details
Report Name	Biochemical Befense - Market
Global Biochemical Befense market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biochemical Befense market, Segment by Type:	Anthrax Smallpox Botulism Radiation/Nuclear Others
Global Biochemical Befense market, by Application	National Defense Military Others
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biochemical Befense companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What are the Application segmentation covered in the Biochemical Befense - Market report?

Ans: The Applications covered in the Biochemical Befense - Market report are National Defense, Military, Others

What are the Type segmentation covered in the Biochemical Befense - Market report?

Ans: The Types covered in the Biochemical Befense - Market report are Anthrax, Smallpox, Botulism, Radiation/Nuclear, Others

1 Market Overview of Biochemical Befense

1.1 Biochemical Befense Market Overview

1.1.1 Biochemical Befense Product Scope

1.1.2 Biochemical Befense Market Status and Outlook

1.2 Global Biochemical Befense Market Size Overview by Region 2018 VS 2022 VS 2029

1.3 Global Biochemical Befense Market Size by Region (2018-2029)

1.4 Global Biochemical Befense Historic Market Size by Region (2018-2023)

1.5 Global Biochemical Befense Market Size Forecast by Region (2024-2029)

1.6 Key Regions, Biochemical Befense Market Size (2018-2029)

1.6.1 North America Biochemical Befense Market Size (2018-2029)

1.6.2 Europe Biochemical Befense Market Size (2018-2029)

1.6.3 Asia-Pacific Biochemical Befense Market Size (2018-2029)

1.6.4 Latin America Biochemical Befense Market Size (2018-2029)

1.6.5 Middle East & Africa Biochemical Befense Market Size (2018-2029)

2 Biochemical Befense Market by Type

2.1 Introduction

2.1.1 Anthrax

2.1.2 Smallpox

2.1.3 Botulism

2.1.4 Radiation/Nuclear

2.1.5 Others

2.2 Global Biochemical Befense Market Size by Type: 2018 VS 2022 VS 2029

2.2.1 Global Biochemical Befense Historic Market Size by Type (2018-2023)

2.2.2 Global Biochemical Befense Forecasted Market Size by Type (2024-2029)

2.3 Key Regions Market Size by Type

2.3.1 North America Biochemical Befense Revenue Breakdown by Type (2018-2029)

2.3.2 Europe Biochemical Befense Revenue Breakdown by Type (2018-2029)

2.3.3 Asia-Pacific Biochemical Befense Revenue Breakdown by Type (2018-2029)

2.3.4 Latin America Biochemical Befense Revenue Breakdown by Type (2018-2029)

2.3.5 Middle East and Africa Biochemical Befense Revenue Breakdown by Type (2018-2029)

3 Biochemical Befense Market Overview by Application

3.1 Introduction

3.1.1 National Defense

3.1.2 Military

3.1.3 Others

3.2 Global Biochemical Befense Market Size by Application: 2018 VS 2022 VS 2029

3.2.1 Global Biochemical Befense Historic Market Size by Application (2018-2023)

3.2.2 Global Biochemical Befense Forecasted Market Size by Application (2024-2029)

3.3 Key Regions Market Size by Application

3.3.1 North America Biochemical Befense Revenue Breakdown by Application (2018-2029)

3.3.2 Europe Biochemical Befense Revenue Breakdown by Application (2018-2029)

3.3.3 Asia-Pacific Biochemical Befense Revenue Breakdown by Application (2018-2029)

3.3.4 Latin America Biochemical Befense Revenue Breakdown by Application (2018-2029)

3.3.5 Middle East and Africa Biochemical Befense Revenue Breakdown by Application (2018-2029)

4 Biochemical Befense Competition Analysis by Players

4.1 Global Biochemical Befense Market Size by Players (2018-2023)

4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biochemical Befense as of 2022)

4.3 Date of Key Players Enter into Biochemical Befense Market

4.4 Global Top Players Biochemical Befense Headquarters and Area Served

4.5 Key Players Biochemical Befense Product Solution and Service

4.6 Competitive Status

4.6.1 Biochemical Befense Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 Emergent Biosolutions

5.1.1 Emergent Biosolutions Profile

5.1.2 Emergent Biosolutions Main Business

5.1.3 Emergent Biosolutions Biochemical Befense Products, Services and Solutions

5.1.4 Emergent Biosolutions Biochemical Befense Revenue (US$ Million) & (2018-2023)

5.1.5 Emergent Biosolutions Recent Developments

5.2 Hytest

5.2.1 Hytest Profile

5.2.2 Hytest Main Business

5.2.3 Hytest Biochemical Befense Products, Services and Solutions

5.2.4 Hytest Biochemical Befense Revenue (US$ Million) & (2018-2023)

5.2.5 Hytest Recent Developments

5.3 GSK

5.3.1 GSK Profile

5.3.2 GSK Main Business

5.3.3 GSK Biochemical Befense Products, Services and Solutions

5.3.4 GSK Biochemical Befense Revenue (US$ Million) & (2018-2023)

5.3.5 Sanofi Recent Developments

5.4 Sanofi

5.4.1 Sanofi Profile

5.4.2 Sanofi Main Business

5.4.3 Sanofi Biochemical Befense Products, Services and Solutions

5.4.4 Sanofi Biochemical Befense Revenue (US$ Million) & (2018-2023)

5.4.5 Sanofi Recent Developments

5.5 PharmAthene

5.5.1 PharmAthene Profile

5.5.2 PharmAthene Main Business

5.5.3 PharmAthene Biochemical Befense Products, Services and Solutions

5.5.4 PharmAthene Biochemical Befense Revenue (US$ Million) & (2018-2023)

5.5.5 PharmAthene Recent Developments

5.6 Bavarian Nordic

5.6.1 Bavarian Nordic Profile

5.6.2 Bavarian Nordic Main Business

5.6.3 Bavarian Nordic Biochemical Befense Products, Services and Solutions

5.6.4 Bavarian Nordic Biochemical Befense Revenue (US$ Million) & (2018-2023)

5.6.5 Bavarian Nordic Recent Developments

5.7 SIGA Technologies

5.7.1 SIGA Technologies Profile

5.7.2 SIGA Technologies Main Business

5.7.3 SIGA Technologies Biochemical Befense Products, Services and Solutions

5.7.4 SIGA Technologies Biochemical Befense Revenue (US$ Million) & (2018-2023)

5.7.5 SIGA Technologies Recent Developments

5.8 Arbutus Biopharma

5.8.1 Arbutus Biopharma Profile

5.8.2 Arbutus Biopharma Main Business

5.8.3 Arbutus Biopharma Biochemical Befense Products, Services and Solutions

5.8.4 Arbutus Biopharma Biochemical Befense Revenue (US$ Million) & (2018-2023)

5.8.5 Arbutus Biopharma Recent Developments

5.9 DynPort Vaccine

5.9.1 DynPort Vaccine Profile

5.9.2 DynPort Vaccine Main Business

5.9.3 DynPort Vaccine Biochemical Befense Products, Services and Solutions

5.9.4 DynPort Vaccine Biochemical Befense Revenue (US$ Million) & (2018-2023)

5.9.5 DynPort Vaccine Recent Developments

5.10 Xoma Corporation

5.10.1 Xoma Corporation Profile

5.10.2 Xoma Corporation Main Business

5.10.3 Xoma Corporation Biochemical Befense Products, Services and Solutions

5.10.4 Xoma Corporation Biochemical Befense Revenue (US$ Million) & (2018-2023)

5.10.5 Xoma Corporation Recent Developments

5.11 Ichor Medical Systems

5.11.1 Ichor Medical Systems Profile

5.11.2 Ichor Medical Systems Main Business

5.11.3 Ichor Medical Systems Biochemical Befense Products, Services and Solutions

5.11.4 Ichor Medical Systems Biochemical Befense Revenue (US$ Million) & (2018-2023)

5.11.5 Ichor Medical Systems Recent Developments

5.12 Aeolus Pharmaceuticals

5.12.1 Aeolus Pharmaceuticals Profile

5.12.2 Aeolus Pharmaceuticals Main Business

5.12.3 Aeolus Pharmaceuticals Biochemical Befense Products, Services and Solutions

5.12.4 Aeolus Pharmaceuticals Biochemical Befense Revenue (US$ Million) & (2018-2023)

5.12.5 Aeolus Pharmaceuticals Recent Developments

5.13 Achaogen

5.13.1 Achaogen Profile

5.13.2 Achaogen Main Business

5.13.3 Achaogen Biochemical Befense Products, Services and Solutions

5.13.4 Achaogen Biochemical Befense Revenue (US$ Million) & (2018-2023)

5.13.5 Achaogen Recent Developments

5.14 Elusys Therapeutics

5.14.1 Elusys Therapeutics Profile

5.14.2 Elusys Therapeutics Main Business

5.14.3 Elusys Therapeutics Biochemical Befense Products, Services and Solutions

5.14.4 Elusys Therapeutics Biochemical Befense Revenue (US$ Million) & (2018-2023)

5.14.5 Elusys Therapeutics Recent Developments

5.15 Dynavax Technologies

5.15.1 Dynavax Technologies Profile

5.15.2 Dynavax Technologies Main Business

5.15.3 Dynavax Technologies Biochemical Befense Products, Services and Solutions

5.15.4 Dynavax Technologies Biochemical Befense Revenue (US$ Million) & (2018-2023)

5.15.5 Dynavax Technologies Recent Developments

5.16 Cleveland BioLabs

5.16.1 Cleveland BioLabs Profile

5.16.2 Cleveland BioLabs Main Business

5.16.3 Cleveland BioLabs Biochemical Befense Products, Services and Solutions

5.16.4 Cleveland BioLabs Biochemical Befense Revenue (US$ Million) & (2018-2023)

5.16.5 Cleveland BioLabs Recent Developments

5.17 Soligenix

5.17.1 Soligenix Profile

5.17.2 Soligenix Main Business

5.17.3 Soligenix Biochemical Befense Products, Services and Solutions

5.17.4 Soligenix Biochemical Befense Revenue (US$ Million) & (2018-2023)

5.17.5 Soligenix Recent Developments

5.18 Alnylam Pharmaceuticals

5.18.1 Alnylam Pharmaceuticals Profile

5.18.2 Alnylam Pharmaceuticals Main Business

5.18.3 Alnylam Pharmaceuticals Biochemical Befense Products, Services and Solutions

5.18.4 Alnylam Pharmaceuticals Biochemical Befense Revenue (US$ Million) & (2018-2023)

5.18.5 Alnylam Pharmaceuticals Recent Developments

6 North America

6.1 North America Biochemical Befense Market Size by Country (2018-2029)

6.2 United States

6.3 Canada

7 Europe

7.1 Europe Biochemical Befense Market Size by Country (2018-2029)

7.2 Germany

7.3 France

7.4 U.K.

7.5 Italy

7.6 Russia

7.7 Nordic Countries

7.8 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific Biochemical Befense Market Size by Region (2018-2029)

8.2 China

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

8.6 India

8.7 Australia

8.8 Rest of Asia-Pacific

9 Latin America

9.1 Latin America Biochemical Befense Market Size by Country (2018-2029)

9.2 Mexico

9.3 Brazil

9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa Biochemical Befense Market Size by Country (2018-2029)

10.2 Turkey

10.3 Saudi Arabia

10.4 UAE

10.5 Rest of Middle East & Africa

11 Biochemical Befense Market Dynamics

11.1 Biochemical Befense Industry Trends

11.2 Biochemical Befense Market Drivers

11.3 Biochemical Befense Market Challenges

11.4 Biochemical Befense Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

FEATURED COMPANIES

Ichor Medical Systems

Aeolus Pharmaceuticals

Alnylam Pharmaceuticals

List of Tables

Table 1. Global Market Biochemical Befense Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029

Table 2. Global Biochemical Befense Market Size by Region (2018-2023) & (US$ Million)

Table 3. Global Biochemical Befense Market Size Share by Region (2018-2023)

Table 4. Global Biochemical Befense Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 5. Global Biochemical Befense Forecasted Market Size Share by Region (2024-2029)

Table 6. Global Biochemical Befense Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029

Table 7. Global Biochemical Befense Market Size by Type (2018-2023) & (US$ Million)

Table 8. Global Biochemical Befense Revenue Market Share by Type (2018-2023)

Table 9. Global Biochemical Befense Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 10. Global Biochemical Befense Revenue Market Share by Type (2024-2029)

Table 11. North America Biochemical Befense Revenue by Type (2018-2023) & (US$ Million)

Table 12. North America Biochemical Befense Revenue by Type (2024-2029) & (US$ Million)

Table 13. Europe Biochemical Befense Revenue by Type (2018-2023) & (US$ Million)

Table 14. Europe Biochemical Befense Revenue by Type (2024-2029) & (US$ Million)

Table 15. Asia-Pacific Biochemical Befense Revenue by Type (2018-2023) & (US$ Million)

Table 16. Asia-Pacific Biochemical Befense Revenue by Type (2024-2029) & (US$ Million)

Table 17. Latin America Biochemical Befense Revenue by Type (2018-2023) & (US$ Million)

Table 18. Latin America Biochemical Befense Revenue by Type (2024-2029) & (US$ Million)

Table 19. Middle East and Africa Biochemical Befense Revenue by Type (2018-2023) & (US$ Million)

Table 20. Middle East and Africa Biochemical Befense Revenue by Type (2024-2029) & (US$ Million)

Table 21. Global Biochemical Befense Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029

Table 22. Global Biochemical Befense Market Size by Application (2018-2023) & (US$ Million)

Table 23. Global Biochemical Befense Revenue Market Share by Application (2018-2023)

Table 24. Global Biochemical Befense Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 25. Global Biochemical Befense Revenue Market Share by Application (2024-2029)

Table 26. North America Biochemical Befense Revenue by Application (2018-2023) & (US$ Million)

Table 27. North America Biochemical Befense Revenue by Application (2024-2029) & (US$ Million)

Table 28. Europe Biochemical Befense Revenue by Application (2018-2023) & (US$ Million)

Table 29. Europe Biochemical Befense Revenue by Application (2024-2029) & (US$ Million)

Table 30. Asia-Pacific Biochemical Befense Revenue by Application (2018-2023) & (US$ Million)

Table 31. Asia-Pacific Biochemical Befense Revenue by Application (2024-2029) & (US$ Million)

Table 32. Latin America Biochemical Befense Revenue by Application (2018-2023) & (US$ Million)

Table 33. Latin America Biochemical Befense Revenue by Application (2024-2029) & (US$ Million)

Table 34. Middle East and Africa Biochemical Befense Revenue by Application (2018-2023) & (US$ Million)

Table 35. Middle East and Africa Biochemical Befense Revenue by Application (2024-2029) & (US$ Million)

Table 36. Global Biochemical Befense Revenue (US$ Million) by Players (2018-2023)

Table 37. Global Biochemical Befense Revenue Market Share by Players (2018-2023)

Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biochemical Befense as of 2022)

Table 39. Date of Key Players Enter into Biochemical Befense Market

Table 40. Global Biochemical Befense Key Players Headquarters and Area Served

Table 41. Biochemical Befense Product Solution and Service

Table 42. Global Biochemical Befense Players Market Concentration Ratio (CR5 and HHI)

Table 43. Mergers & Acquisitions, Expansion Plans

Table 44. Emergent Biosolutions Basic Information List

Table 45. Emergent Biosolutions Description and Business Overview

Table 46. Emergent Biosolutions Biochemical Befense Products, Services and Solutions

Table 47. Revenue (US$ Million) in Biochemical Befense Business of Emergent Biosolutions (2018-2023)

Table 48. Emergent Biosolutions Recent Developments

Table 49. Hytest Basic Information List

Table 50. Hytest Description and Business Overview

Table 51. Hytest Biochemical Befense Products, Services and Solutions

Table 52. Revenue (US$ Million) in Biochemical Befense Business of Hytest (2018-2023)

Table 53. Hytest Recent Developments

Table 54. GSK Basic Information List

Table 55. GSK Description and Business Overview

Table 56. GSK Biochemical Befense Products, Services and Solutions

Table 57. Revenue (US$ Million) in Biochemical Befense Business of GSK (2018-2023)

Table 58. GSK Recent Developments

Table 59. Sanofi Basic Information List

Table 60. Sanofi Description and Business Overview

Table 61. Sanofi Biochemical Befense Products, Services and Solutions

Table 62. Revenue (US$ Million) in Biochemical Befense Business of Sanofi (2018-2023)

Table 63. Sanofi Recent Developments

Table 64. PharmAthene Basic Information List

Table 65. PharmAthene Description and Business Overview

Table 66. PharmAthene Biochemical Befense Products, Services and Solutions

Table 67. Revenue (US$ Million) in Biochemical Befense Business of PharmAthene (2018-2023)

Table 68. PharmAthene Recent Developments

Table 69. Bavarian Nordic Basic Information List

Table 70. Bavarian Nordic Description and Business Overview

Table 71. Bavarian Nordic Biochemical Befense Products, Services and Solutions

Table 72. Revenue (US$ Million) in Biochemical Befense Business of Bavarian Nordic (2018-2023)

Table 73. Bavarian Nordic Recent Developments

Table 74. SIGA Technologies Basic Information List

Table 75. SIGA Technologies Description and Business Overview

Table 76. SIGA Technologies Biochemical Befense Products, Services and Solutions

Table 77. Revenue (US$ Million) in Biochemical Befense Business of SIGA Technologies (2018-2023)

Table 78. SIGA Technologies Recent Developments

Table 79. Arbutus Biopharma Basic Information List

Table 80. Arbutus Biopharma Description and Business Overview

Table 81. Arbutus Biopharma Biochemical Befense Products, Services and Solutions

Table 82. Revenue (US$ Million) in Biochemical Befense Business of Arbutus Biopharma (2018-2023)

Table 83. Arbutus Biopharma Recent Developments

Table 84. DynPort Vaccine Basic Information List

Table 85. DynPort Vaccine Description and Business Overview

Table 86. DynPort Vaccine Biochemical Befense Products, Services and Solutions

Table 87. Revenue (US$ Million) in Biochemical Befense Business of DynPort Vaccine (2018-2023)

Table 88. DynPort Vaccine Recent Developments

Table 89. Xoma Corporation Basic Information List

Table 90. Xoma Corporation Description and Business Overview

Table 91. Xoma Corporation Biochemical Befense Products, Services and Solutions

Table 92. Revenue (US$ Million) in Biochemical Befense Business of Xoma Corporation (2018-2023)

Table 93. Xoma Corporation Recent Developments

Table 94. Ichor Medical Systems Basic Information List

Table 95. Ichor Medical Systems Description and Business Overview

Table 96. Ichor Medical Systems Biochemical Befense Products, Services and Solutions

Table 97. Revenue (US$ Million) in Biochemical Befense Business of Ichor Medical Systems (2018-2023)

Table 98. Ichor Medical Systems Recent Developments

Table 99. Aeolus Pharmaceuticals Basic Information List

Table 100. Aeolus Pharmaceuticals Description and Business Overview

Table 101. Aeolus Pharmaceuticals Biochemical Befense Products, Services and Solutions

Table 102. Revenue (US$ Million) in Biochemical Befense Business of Aeolus Pharmaceuticals (2018-2023)

Table 103. Aeolus Pharmaceuticals Recent Developments

Table 104. Achaogen Basic Information List

Table 105. Achaogen Description and Business Overview

Table 106. Achaogen Biochemical Befense Products, Services and Solutions

Table 107. Revenue (US$ Million) in Biochemical Befense Business of Achaogen (2018-2023)

Table 108. Achaogen Recent Developments

Table 109. Elusys Therapeutics Basic Information List

Table 110. Elusys Therapeutics Description and Business Overview

Table 111. Elusys Therapeutics Biochemical Befense Products, Services and Solutions

Table 112. Revenue (US$ Million) in Biochemical Befense Business of Elusys Therapeutics (2018-2023)

Table 113. Elusys Therapeutics Recent Developments

Table 114. Dynavax Technologies Basic Information List

Table 115. Dynavax Technologies Description and Business Overview

Table 116. Dynavax Technologies Biochemical Befense Products, Services and Solutions

Table 117. Revenue (US$ Million) in Biochemical Befense Business of Dynavax Technologies (2018-2023)

Table 118. Dynavax Technologies Recent Developments

Table 119. Cleveland BioLabs Basic Information List

Table 120. Cleveland BioLabs Description and Business Overview

Table 121. Cleveland BioLabs Biochemical Befense Products, Services and Solutions

Table 122. Revenue (US$ Million) in Biochemical Befense Business of Cleveland BioLabs (2018-2023)

Table 123. Cleveland BioLabs Recent Developments

Table 124. Soligenix Basic Information List

Table 125. Soligenix Description and Business Overview

Table 126. Soligenix Biochemical Befense Products, Services and Solutions

Table 127. Revenue (US$ Million) in Biochemical Befense Business of Soligenix (2018-2023)

Table 128. Soligenix Recent Developments

Table 129. Alnylam Pharmaceuticals Basic Information List

Table 130. Alnylam Pharmaceuticals Description and Business Overview

Table 131. Alnylam Pharmaceuticals Biochemical Befense Products, Services and Solutions

Table 132. Revenue (US$ Million) in Biochemical Befense Business of Alnylam Pharmaceuticals (2018-2023)

Table 133. Alnylam Pharmaceuticals Recent Developments

Table 134. North America Biochemical Befense Market Size by Country (2018-2023) & (US$ Million)

Table 135. North America Biochemical Befense Market Size by Country (2024-2029) & (US$ Million)

Table 136. Europe Biochemical Befense Market Size by Country (2018-2023) & (US$ Million)

Table 137. Europe Biochemical Befense Market Size by Country (2024-2029) & (US$ Million)

Table 138. Asia-Pacific Biochemical Befense Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 139. Asia-Pacific Biochemical Befense Market Size by Region (2018-2023) & (US$ Million)

Table 140. Asia-Pacific Biochemical Befense Market Size by Region (2024-2029) & (US$ Million)

Table 141. Asia-Pacific Biochemical Befense Market Share by Region (2018-2023)

Table 142. Asia-Pacific Biochemical Befense Market Share by Region (2024-2029)

Table 143. Latin America Biochemical Befense Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 144. Latin America Biochemical Befense Market Size by Country (2018-2023) & (US$ Million)

Table 145. Latin America Biochemical Befense Market Size by Country (2024-2029) & (US$ Million)

Table 146. Middle East & Africa Biochemical Befense Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 147. Middle East & Africa Biochemical Befense Market Size by Country (2018-2023) & (US$ Million)

Table 148. Middle East & Africa Biochemical Befense Market Size by Country (2024-2029) & (US$ Million)

Table 149. Biochemical Befense Market Trends

Table 150. Biochemical Befense Market Drivers

Table 151. Biochemical Befense Market Challenges

Table 152. Biochemical Befense Market Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Biochemical Befense Market Size Year-over-Year 2018-2029 & (US$ Million)

Figure 2. Global Biochemical Befense Market Size (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Biochemical Befense Market Share by Regions: 2022 VS 2029

Figure 4. Global Biochemical Befense Forecasted Market Size Share by Region (2024-2029)

Figure 5. North America Biochemical Befense Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 6. Europe Biochemical Befense Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 7. Asia-Pacific Biochemical Befense Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 8. Latin America Biochemical Befense Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 9. Middle East & Africa Biochemical Befense Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 10. Product Picture of Anthrax

Figure 11. Global Anthrax Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 12. Product Picture of Smallpox

Figure 13. Global Smallpox Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 14. Product Picture of Botulism

Figure 15. Global Botulism Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 16. Product Picture of Radiation/Nuclear

Figure 17. Global Radiation/Nuclear Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 18. Product Picture of Others

Figure 19. Global Others Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 20. Global Biochemical Befense Market Size Share by Type: 2022 & 2029

Figure 21. North America Biochemical Befense Revenue Market Share by Type (2018-2029)

Figure 22. Europe Biochemical Befense Revenue Market Share by Type (2018-2029)

Figure 23. Asia-Pacific Biochemical Befense Revenue Market Share by Type (2018-2029)

Figure 24. Latin America Biochemical Befense Revenue Market Share by Type (2018-2029)

Figure 25. Middle East and Africa Biochemical Befense Revenue Market Share by Type (2018-2029)

Figure 26. National Defense Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 27. Military Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 28. Others Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 29. Global Biochemical Befense Market Size Share by Application: 2022 & 2029

Figure 30. North America Biochemical Befense Revenue Market Share by Application (2018-2029)

Figure 31. Europe Biochemical Befense Revenue Market Share by Application (2018-2029)

Figure 32. Asia-Pacific Biochemical Befense Revenue Market Share by Application (2018-2029)

Figure 33. Latin America Biochemical Befense Revenue Market Share by Application (2018-2029)

Figure 34. Middle East and Africa Biochemical Befense Revenue Market Share by Application (2018-2029)

Figure 35. Biochemical Befense Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 36. Global Top 5 and Top 10 Players Biochemical Befense Market Share in 2022

Figure 37. North America Biochemical Befense Market Share by Country (2018-2029)

Figure 38. United States Biochemical Befense Market Size (2018-2029) & (US$ Million)

Figure 39. Canada Biochemical Befense Market Size (2018-2029) & (US$ Million)

Figure 40. Germany Biochemical Befense Market Size (2018-2029) & (US$ Million)

Figure 41. France Biochemical Befense Market Size (2018-2029) & (US$ Million)

Figure 42. U.K. Biochemical Befense Market Size (2018-2029) & (US$ Million)

Figure 43. Italy Biochemical Befense Market Size (2018-2029) & (US$ Million)

Figure 44. Russia Biochemical Befense Market Size (2018-2029) & (US$ Million)

Figure 45. Nordic Countries Biochemical Befense Market Size (2018-2029) & (US$ Million)

Figure 46. Asia-Pacific Biochemical Befense Market Share by Region (2018-2029)

Figure 47. China Biochemical Befense Market Size (2018-2029) & (US$ Million)

Figure 48. Japan Biochemical Befense Market Size (2018-2029) & (US$ Million)

Figure 49. South Korea Biochemical Befense Market Size (2018-2029) & (US$ Million)

Figure 50. Southeast Asia Biochemical Befense Market Size (2018-2029) & (US$ Million)

Figure 51. India Biochemical Befense Market Size (2018-2029) & (US$ Million)

Figure 52. Australia Biochemical Befense Market Size (2018-2029) & (US$ Million)

Figure 53. Latin America Biochemical Befense Market Share by Country (2018-2029)

Figure 54. Mexico Biochemical Befense Market Size (2018-2029) & (US$ Million)

Figure 55. Brazil Biochemical Befense Market Size (2018-2029) & (US$ Million)

Figure 56. Middle East & Africa Biochemical Befense Market Share by Country (2018-2029)

Figure 57. Turkey Biochemical Befense Market Size (2018-2029) & (US$ Million)

Figure 58. Saudi Arabia Biochemical Befense Market Size (2018-2029) & (US$ Million)

Figure 59. UAE Biochemical Befense Market Size (2018-2029) & (US$ Million)

Figure 60. Bottom-up and Top-down Approaches for This Report

SELECT A FORMAT

Added to Cart

Single User

Electronic

$3350

Single User License

Multi User

Electronic

$5025

Multi User License

Enterprise License

Electronic

$6700

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions